precancer

Skip to content The CRC Digest Blood-Based Screening Biomarkers Under Review Researchers identified novel blood test candidates that could complement or enhance current colorectal cancer screening approaches. (Clinical Colorectal Cancer) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The

Skip to content The CRC Digest ctDNA Among Novel Screening Biomarkers Systematic review highlights circulating tumor DNA as a candidate for blood-based colorectal cancer screening. (Clinical Colorectal Cancer) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC Digest

Skip to content The CRC Digest ▪ Review Identifies Promising Blood-Based Biomarkers for CRC Screening A systematic review examined novel blood tests, including circulating tumor DNA (ctDNA), that could help detect colorectal cancer and precancerous conditions earlier through less invasive screening methods. (Clinical Colorectal Cancer) This content is informational only and